Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Pentagon City Hotel

Mar 14, 2024 7:30 AM - Mar 15, 2024 4:15 PM

900 South Orme Street, Arlington, VA 22204, USA

Global Labeling Conference

Join speakers from around the world sharing their labeling – Germany, Japan, Belgium, UK, Canada and more!

Session 7: eLabeling: Patient Interactions, Advanced e-Labeling Initiatives, and Public/Private Consortia Insights

Session Chair(s)

Theresa  Brunone, MLS, MS

Theresa Brunone, MLS, MS

Head-Labelling Compliance and Implementation, Global Labeling

GlaxoSmithKline, United States

Kathleen  Salazar, MA, MBA

Kathleen Salazar, MA, MBA

Head, Global Labeling Implementation

Johnson & Johnson Innovative Medicine, United States

While a key focus of e-labeling is how and when labels are converted from paper to digital, important aspects of e-labeling and its adoption go beyond the conversion itself. A key measure of value is patient benefit, including accessibility of elabeling across patient populations, interoperability across various points of care and care providers, and personalization to the individual patient. And a key enabler to driving forward e-labeling is Health Authority engagement and support. This session will address regulator interactions, early-stage developments, and global adoption patterns around e-labeling as well as patient benefits and interactions through key e-labeling initiatives.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss regulator interactions, early-stage developments, and global adoption patterns for e-labeling
  • Identify key concepts and technologies related to interoperability across care platforms and within the end-to-end labeling process
  • Describe select in-flight patient-focused e-labeling initiatives and their current status

Speaker(s)

Giovanna  Ferrari, PhD

Gravitate-Health… Unlocking the Value in Electronic Product Information (ePI) for the Patient – Taking a Global Approach

Giovanna Ferrari, PhD

Pfizer Ltd, United Kingdom

Regional Labelling Lead, Senior Director

Yuri  Quintana, PhD

Co-Creating New Ways to Communicate Medication Information to Patients

Yuri Quintana, PhD

Beth Israel Deaconess Medical Center, United States

Chief, Division of Clinical Informatics

G. Scott  Gordon, PhD

FDA SPL-on-FHIR: Opportunities for Modernization and International Harmonization of Product Information

G. Scott Gordon, PhD

FDA, United States

Senior Health Informatics Officer, OSP, CDER

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.